How JustAnswer Works:
  • Ask an Expert
    Experts are full of valuable knowledge and are ready to help with any question. Credentials confirmed by a Fortune 500 verification firm.
  • Get a Professional Answer
    Via email, text message, or notification as you wait on our site. Ask follow up questions if you need to.
  • 100% Satisfaction Guarantee
    Rate the answer you receive.
Ask khagihara Your Own Question
khagihara
khagihara, Doctor
Category: Medical
Satisfied Customers: 6590
Experience:  Trained in the multiple medical fields for many years.
20084961
Type Your Medical Question Here...
khagihara is online now
A new question is answered every 9 seconds

I have a completely blocked arterie in my right leg from

Customer Question

hi i have a completely blocked arterie in my right leg from almost my groin to just above my knee i am get blood from shoots that supply blood to my lower leg what can be done about this problem
JA: What seems to make the symptoms worse or better? Have you noticed any swelling?
Customer: no no swelling when i walk my calf mussel gets real tight and hurts and my foot get a little warm or hot i do keep walking and the pain reduces a little after a while
JA: Anything else in your medical history you think the doctor should know?
Customer: i have seen a coctor but he said a ballon or stint would be no good just keep walking. i am not to happy about that advice what do you think i should do.
Submitted: 9 months ago.
Category: Medical
Expert:  khagihara replied 9 months ago.

Your doctor is right. For most patients with claudication, we recommend an initial medical treatment regimen that includes risk reduction, exercise therapy (for those who can participate), and possibly pharmacologic therapy, rather than initial vascular intervention. Symptoms of claudication are associated with a low risk of progression to limb-threatening lower extremity ischemia, and a major concern with intervention is that some patients may suffer complications that worsen their symptoms. A subset of patients with severe claudication and inflow disease may benefit from early vascular intervention.

For patients who can participate in exercise therapy, we suggest supervised rather than unsupervised exercise therapy, where available. The value of an unsupervised exercise program is less well studied, but can still generally be recommended for patients who cannot participate in a supervised exercise program. Exercise therapy should be performed for a minimum of 30 to 45 minutes at least three times per week for a minimum of 12 weeks prior to reevaluation. During each session, an exercise level that is of sufficient intensity to elicit claudication should be achieved.

For most patients with lifestyle-limiting claudication who do not have an improvement in symptoms with risk modification and exercise therapy, we suggest a therapeutic trial of naftidrofuryl or cilostazol (100 mg twice daily) depending upon availability. Naftidrofuryl has fewer side effects, and where both are available, naftidrofuryl can be tried first. If the effect is not sufficient, then changing to cilostazol is appropriate.

We schedule follow-up after three months to assess the effectiveness of the initial medical therapy regimen for reducing symptoms. Patients who show improvement and who are satisfied with their progress can be scheduled for annual vascular examination. For patients who have been compliant with risk reduction strategies, yet six months to a year of exercise therapy and adjunctive pharmacotherapy have failed to provide satisfactory improvement, referral for possible revascularization is appropriate.

Options for revascularization include percutaneous intervention, surgical bypass, or a combination of these, and the choice depends upon the level of obstruction (aortoiliac, femoropopliteal) and severity of disease, and the patient’s risk for the intervention. We agree with major cardiovascular society guidelines that recommend an initial attempt at percutaneous revascularization, reserving surgery for when arterial anatomy is not favorable for a percutaneous approach, provided the patient has an acceptable risk for surgery.

Customer: replied 9 months ago.
i thank you for your reply,i am satisfied with your anwserand will take it onboard.
Expert:  khagihara replied 9 months ago.

You are welcome. Please rate my answer. Thank you.